6/8/2012 10:05:25 AM
PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals (NASDAQ:ANAC) will host an Investor Day for institutional investors and research analysts on Thursday, June 21, 2012 from 8:00 a.m. to 1:00 p.m. ET in New York, New York. The meeting will focus on the development of its two lead compounds - tavaborole for onychomycosis and AN2728 for atopic dermatitis and psoriasis. Experts in the fields of podiatry and dermatology will be featured speakers at the meeting.
comments powered by